Amy Esler is associate professor of pediatrics at the University of Minnesota in Minneapolis.
![](https://www.thetransmitter.org/wp-content/uploads/2018/03/show-image.jpg)
Amy Esler
Assistant Professor of Pediatrics
University of Minnesota
From this contributor
Why we need a mouse version of a diagnostic test for autism
Researchers have developed behavioral measures that can accurately diagnose autism in people; these lessons can and should be applied to mice.
![scientist looks through binoculars showing a boy on one side, and a mouse on the other.](https://www.thetransmitter.org/wp-content/uploads/2018/03/Spectrum_SpecialReport_Mice_ADOS_Roughs_FINAL.jpg)
Why we need a mouse version of a diagnostic test for autism
Adjusting diagnostic tests for the DSM-5
As clinicians adopt the new criteria for autism, the many tests now used to diagnose the disorder may need to be modified, says Amy Esler.
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.